BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7001396)

  • 1. [75Se -- selenocholesterol -- a new radionuclide for adrenal scintiscanning. Preliminary clinical investigations (author's transl)].
    Jakubowski W; Mariss P
    Pol Przegl Radiol Med Nukl; 1980; 44(3):223-5. PubMed ID: 7001396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Scintigraphic investigations of the adrenals by means of 75Se-selenocholesterol (author's transl)].
    Jakubowski W; Feltynowski T; Graban W
    Pol Przegl Radiol Med Nukl; 1980; 44(4):307-10. PubMed ID: 7243634
    [No Abstract]   [Full Text] [Related]  

  • 3. Selenium 75 selenomethyl cholesterol: a new agent for quantitative functional scintigraphy of the adrenals: physical aspects.
    Hawkins LA; Britton KE; Shapiro B
    Br J Radiol; 1980 Sep; 53(633):883-9. PubMed ID: 7437711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of 6-methyl-75Se-selenomethyl-19-nor-cholest-5(10)-en-3 beta-ol (Scintadren) (author's transl)].
    Takahashi T; Yamazaki M; Haruyama K; Fukuch S; Kida T
    Kaku Igaku; 1980 Mar; 17(2):211-7. PubMed ID: 7382186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenal scintigraphy with 75Se-Scintadren: localizing diagnosis of adrenal adenoma in primary aldosteronism (author's transl)].
    Kobayashi T; Ishii K; Nakazawa K; Yoda K; Matsubayashi T
    Kaku Igaku; 1980 Jul; 17(5):607-14. PubMed ID: 7420767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
    Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
    Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
    [No Abstract]   [Full Text] [Related]  

  • 7. Radionuclide imaging of the adrenal glands.
    Chatal JF; Charbonnel B; Guihard D
    Clin Nucl Med; 1978 Feb; 3(2):71-6. PubMed ID: 657660
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)].
    Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S
    Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical value of isotope methods in adrenal morphology investigations (author's transl)].
    Jakubowski W; Feltynowski T; Graban W
    Pol Przegl Radiol Med Nukl; 1981; 45(5):281-7. PubMed ID: 7342057
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.
    Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC
    Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tomodensitometry: localizing value in hypertension of adrenal origin (author's transl)].
    Colliard M; Baglin A; Perez R; Bijard A; Garnier H; Duprey J; Tcherdakoff P; Fritel D
    Nouv Presse Med; 1979 Aug 25-Sep 3; 8(33):2669-72. PubMed ID: 493067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphy of the adrenal glands using 75Se-selenocholesterol (Scintadren).
    Jakubowski W; Graban W; Feltynowski T; Bazko E; Elwertowski M
    Radiobiol Radiother (Berl); 1982; 23(3):325-32. PubMed ID: 7178467
    [No Abstract]   [Full Text] [Related]  

  • 13. The diagnostic significance of the various radiological examinations in adrenal disease.
    Sasaki T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1978 May; 38(5):416-22. PubMed ID: 693258
    [No Abstract]   [Full Text] [Related]  

  • 14. Selenium-75-cholesterol imaging and computed tomography of the adrenal glands in differentiating the cause of Cushing's syndrome.
    Miller JL; Smith JA; Mervis B; Roman T
    S Afr Med J; 1983 May; 63(22):848-50. PubMed ID: 6857400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with 75Se selenomethylcholesterol adrenal imaging.
    Shapiro B; Britton KE; Hawkins LA; Edwards CR
    Clin Endocrinol (Oxf); 1981 Jul; 15(1):19-27. PubMed ID: 7307282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of adrenal diseases with a new adrenal-scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5(10)-en-3 beta-ol (author's transl)].
    Seto H; Futatsuya R; Kakishita M; Mori H; Hisada K
    Radioisotopes; 1980 May; 29(5):247-9. PubMed ID: 7414016
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical use of 131I-19-iodocholesterol adrenal scintiphotography.
    Chin Med J (Engl); 1979 Apr; 92(4):233-6. PubMed ID: 108054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
    Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
    Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
    [No Abstract]   [Full Text] [Related]  

  • 19. 131I-6-iodocholesterol, an agent for imaging the adrenal gland.
    Jixiao M; Ruisen Z
    Chin Med J (Engl); 1979 Apr; 92(4):237-46. PubMed ID: 108055
    [No Abstract]   [Full Text] [Related]  

  • 20. [Scintigraphic investigations of adrenals in the diagnosis of primary hyperaldosteronism syndrome (author's transl)].
    Jakubowski W; Feltynowski T; Graban W
    Pol Przegl Radiol Med Nukl; 1980; 44(6):449-52. PubMed ID: 7255238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.